Renal osteodystrophy in chronic kidney disease results from which combination of mineral abnormalities?

• A. Hypercalcemia and hypophosphatemia
• B. Chronic hyperphosphatemia, hypocalcemia, and secondary hyperparathyroidism
• C. Increased vitamin D and phosphate excretion
• D. Normal bone turnover with aging

Answer: (B)

Renal osteodystrophy in CKD arises from how kidney failure disrupts mineral metabolism. The failing kidneys can’t excrete phosphate effectively, so phosphate levels rise (hyperphosphatemia). This excess phosphate binds calcium, leading to lower serum calcium (hypocalcemia). The fall in calcium stimulates the parathyroid glands to release more parathyroid hormone—secondary hyperparathyroidism. At the same time, the kidneys lose the ability to activate vitamin D, reducing intestinal calcium absorption and worsening hypocalcemia, which further drives PTH release. The combination of high phosphate, low calcium, and secondary hyperparathyroidism explains the bone changes seen in renal osteodystrophy. The other patterns described—hypercalcemia with low phosphate, increased vitamin D and phosphate excretion, or normal bone turnover with aging—do not fit the CKD-related mineral disturbances.